Hepion Pharmaceuticals appoints Dr. Kaouthar Lbiati as interim CEO as it pivots to diagnostic tests for celiac, COVID, liver cancer and more.

Robert Foster's loved ones are hoping for a miracle days after the boater went missing in Lake Michigan at 63rd Street Beach, near Jackson Park.

Dr. Lbiati’s appointment signals a new chapter for Hepion—one focused on strategic renewal, value creation, and diagnostic innovation in areas of significant unmet clinical need, including ...

Hepion Pharmaceuticals appoints Dr. Kaouthar Lbiati as Interim Chief Executive Officer, highlighting leadership changes within the company.

Hepion’s transformation is grounded in delivering immediate impact through disciplined execution and rapid commercialization of both CE-marked tests in Europe and the UK, and U.S. regulatory ...

MORRISTOWN, N.J., June 16, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (OTC:HEPA), a clinical stage biopharmaceutical company that is developing and commercializing diagnostic tests for ...

MORRISTOWN, N.J., June 25, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (OTCQB:HEPA), a clinical stage biopharmaceutical company that is developing and commercializing diagnostic tests ...

Hepion Pharmaceuticals Successfully Completes Application to the OTCQB 2 Klicks für mehr Datenschutz: Klicken sie bitte 2x um die Empfehlung zu senden – siehe i.nicht mit Facebook verbunden ...

MORRISTOWN, N.J., June 25, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (OTCQB:HEPA), a clinical stage biopharmaceutical company that is developing and commercializing diagnostic tests for ...